ABSTRACT. This review goes through the development of the glucose‐controlled insulin infusion systems. The closed‐loop system, Biostator®, is described with discussion of demands on technique and function. It deals with the applicability of the glucose sensor in normalizing the diabetic mal‐metabolism and selection of any glucose control wanted in experimental situations. The role of the glucose‐sensor in clinical use and as a research tool are discussed.